Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
HB2117 • 2025
Restores the corporate excise tax credit allowed for qualified research activities at an increased maximum amount.
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
The plain English breakdown is still being put together. The official documents below are already here.
In committee upon adjournment.
Referred to Revenue.
First reading. Referred to Speaker's desk.
Digest: The Act brings back a tax credit for research expenditures. (Flesch Readability Score: 69.7). Restores the corporate excise tax credit allowed for qualified research activities at an increased maximum amount. Provides for refundability and transferability of the credit. Allows the option for research and development expenditures to be fully deducted in the tax year paid or incurred, rather than treated as capital expenditures and amortized over five years. Applies to tax years beginning on or after January 1, 2025, and before January 1, 2031. Takes effect on the 91st day following adjournment sine die. Relating to: Relating to tax treatment of research expenditures; prescribing an effective date. Current location: In House Committee